德国抗发作药物短缺:这个问题有多大?
Josephine Steidl1, Sabine Krebs2, Karel Kostev3
1Department of Neurology, Epilepsy Center Erlangen, Full Member of ERN EpiCARE, University Hospital Erlangen, Schwabachanlage 6, 91054 Erlangen, Germany.
Epilepsy & behavior : E&B
|November 30, 2024
概括
药物短缺影响了2023年7月德国11%至15%的抗发作药物 (ASM) 配方. 一般的ASM和大约三分之二的制造商更频繁地经历了这些短缺.
科学领域:
- 药理学和制药科学 药理学和制药科学
- 医疗保健服务研究 医疗服务研究
- 药物供应链管理 药物供应链管理
背景情况:
- 药物短缺对全球患者护理和医疗保健系统构成重大挑战.
- 抗发作药物 (ASM) 对于治疗和其他神经疾病至关重要.
- 了解ASM短缺的流行和模式对于积极的缓解策略至关重要.
研究的目的:
- 确定德国抗发作药物 (ASM) 药物短缺和中断的频率.
- 分析配方,ASM和制造商层面的短缺问题.
- 确定受可用性问题影响最大的特定ASM和制造商.
主要方法:
- 德国制药批发商数据库的回顾性分析 (2023年7月).
- 包括来自两个主要批发商的数据,占德国市场约45%.
- 专注于确定ASM配方和制造商的药物短缺 (未满足需求) 和干扰 (完全未满足需求).
主要成果:
- 10.8%至15%的ASM配方在两个主要批发商中经历了药物短缺.
- 显著的制造商参与,其中63.2%至66.1%报告短缺.
- 与品牌药物 (16.7%) 相比,通用ASM受到的影响不成比例 (83.3%).
- 普雷加巴林, levetiracetam 和 carbamazepine 是最经常受到影响的化合物.
结论:
- 在2023年7月,在德国,大量的ASM配方 (11%-15%) 面临着药物短缺问题.
- 通用抗发作药物比他们的品牌同行更容易受到短缺的影响.
- 一个很高的百分比的制造商报告药物短缺,表明系统性供应链问题.
相关概念视频
Antiepileptic Drugs: GABAergic Pathway Potentiators
333
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
333
Antiepileptic Drugs: Potassium Channel Activators
146
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
146
Antiepileptic Drugs: Calcium Channel Blockers
320
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
320
Antiepileptic Drugs: Sodium Channel Blockers
426
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
426
Arteries of the Lower Limbs
177
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
177
Antiepileptic Drugs: Glutamate Antagonists
283
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
283


